Table I.
Characteristics of subjects infected with hMPV
Group | Number | Age | Sex | Serum IgE level (IU/mL) | Month of admission |
---|---|---|---|---|---|
Wheezing subjects | ∗1 | 2 mo | F | <2.0 | Oct |
∗2 | 2 mo | M | <2.0 | Jan | |
3 | 4 mo | M | <3.0 | Jan | |
4 | 8 mo | F | <2.0 | Mar | |
∗5 | 9 mo | F | 2.45 | Feb | |
6 | 12 mo | F | 14.4 | Mar | |
7 | 13 mo | M | 33.7 | Jan | |
8 | 5 y | F | 27.6 | Apr | |
9 | 8 y | M | 145 | Apr | |
10 | 9 y | M | 548 | Jan | |
Mean, 128 | |||||
Control subjects | ∗11 | 6 mo | F | <2.0 | Mar |
12 | 5 y | M | 66.4 | Feb | |
13 | 9 y | F | 1053 | Oct | |
Mean, 560 |
These subjects also tested positive for other viruses, including parainfluenza virus (subject 1); cytomegalovirus (subject 2); adenovirus, RSV, cytomegalovirus, and parainfluenza virus (subject 5); and rhinovirus and parainfluenza virus (subject 11).